Literature DB >> 1324408

Roles of insulinlike growth factor 1 (IGF-1) and the IGF-1 receptor in epidermal growth factor-stimulated growth of 3T3 cells.

Z Pietrzkowski1, C Sell, R Lammers, A Ullrich, R Baserga.   

Abstract

BALB/c3T3 cells are exquisitely growth regulated and require platelet-derived growth factor, epidermal growth factor (EGF), and insulinlike growth factor 1 (IGF-1) for growth. When BALB/c3T3 cells are transfected with plasmids constitutively expressing both EGF and the human IGF-1 receptor mRNAs, the cells are capable of growing in serum-free medium without the addition of any exogenous growth factor. These cells, called p5 cells, can grow for prolonged periods in serum-free medium. BALB/c3T3 cells transfected with only the IGF-1 receptor expression plasmid (p6 cells) do not grow in serum-free medium but do grow if IGF-1 (or insulin in supraphysiological concentrations) is added. p6 cells also grow in response to EGF, confirming that the combination of EGF and an overexpressed IGF-1 receptor is sufficient for the growth of 3T3 cells. We have found that in EGF-stimulated p6 cells there is an increase in the expression of IGF-1 mRNA, that IGF-1 is secreted into the medium, and that the growth of p5 cells and EGF-stimulated p6 cells is inhibited by exposure to antisense oligodeoxynucleotides to IGF-1 receptor RNA. Finally, while cells constitutively expressing both EGF and EGF receptor RNAs grow, albeit modestly, in serum-free medium, their growth is also inhibited by an antisense oligodeoxynucleotide to IGF-1 receptor RNA. In contrast, in cells overexpressing the IGF-1 receptor, IGF-1-mediated cell growth occurs independently of the platelet-derived growth factor and EGF receptors (Z. Pietrzkowski, R. Lammers, G. Carpenter, A. M. Soderquist, M. Limardo, P. D. Phillips, A. Ullrich, and R. Baserga, Cell Growth Differ. 3:199-205, 1992, and this paper). These data indicate that an important role for EGF is participation in the activation of an autocrine loop based on the IGF-1-IGF-1 receptor interaction, which is obligatory for the proliferation of 3T3 cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324408      PMCID: PMC360264          DOI: 10.1128/mcb.12.9.3883-3889.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

1.  Classification system based on the functional equivalency of mitogens that regulate WI-38 cell proliferation.

Authors:  P D Phillips; V J Cristofalo
Journal:  Exp Cell Res       Date:  1988-04       Impact factor: 3.905

2.  Abrogation of the requirements for added growth factors in 3T3 cells constitutively expressing the p53 and IGF-1 genes.

Authors:  X X Gai; M G Rizzo; J Lee; A Ullrich; R Baserga
Journal:  Oncogene Res       Date:  1988

3.  Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer.

Authors:  F Pekonen; S Partanen; T Mäkinen; E M Rutanen
Journal:  Cancer Res       Date:  1988-03-01       Impact factor: 12.701

4.  Ligand activation of overexpressed epidermal growth factor receptors transforms NIH 3T3 mouse fibroblasts.

Authors:  H Riedel; S Massoglia; J Schlessinger; A Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

5.  Epidermal growth factor (EGF) and somatomedin C regulate G1 progression in competent BALB/c-3T3 cells.

Authors:  E B Leof; W Wharton; J J van Wyk; W J Pledger
Journal:  Exp Cell Res       Date:  1982-09       Impact factor: 3.905

6.  Transforming potential of the c-fms proto-oncogene (CSF-1 receptor).

Authors:  M F Roussel; T J Dull; C W Rettenmier; P Ralph; A Ullrich; C J Sherr
Journal:  Nature       Date:  1987 Feb 5-11       Impact factor: 49.962

7.  Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts.

Authors:  J S Flier; P Usher; A C Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

8.  Evidence for autocrine mitogenic stimulation by somatomedin-C/insulin-like growth factor I on an established human lung cancer cell line.

Authors:  F Minuto; P Del Monte; A Barreca; A Alama; G Cariola; G Giordano
Journal:  Cancer Res       Date:  1988-07-01       Impact factor: 12.701

9.  Sequences of liver cDNAs encoding two different mouse insulin-like growth factor I precursors.

Authors:  G I Bell; M M Stempien; N M Fong; L B Rall
Journal:  Nucleic Acids Res       Date:  1986-10-24       Impact factor: 16.971

10.  Characterization of insulin, insulin-like growth factors I and II, and growth hormone receptors on human leukemic lymphoblasts.

Authors:  P D Lee; R G Rosenfeld; R L Hintz; S D Smith
Journal:  J Clin Endocrinol Metab       Date:  1986-01       Impact factor: 5.958

View more
  14 in total

1.  Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma.

Authors:  J Anderson; A Gordon; A McManus; J Shipley; K Pritchard-Jones
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

Review 2.  The role of liver-derived insulin-like growth factor-I.

Authors:  Claes Ohlsson; Subburaman Mohan; Klara Sjögren; Asa Tivesten; Jörgen Isgaard; Olle Isaksson; John-Olov Jansson; Johan Svensson
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

3.  Repression of platelet-derived growth factor beta-receptor expression by mitogenic growth factors and transforming oncogenes in murine 3T3 fibroblasts.

Authors:  C Vaziri; D V Faller
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

4.  Nuclear insulin-like growth factor 1 receptor phosphorylates proliferating cell nuclear antigen and rescues stalled replication forks after DNA damage.

Authors:  Ahmed Waraky; Yingbo Lin; Dudi Warsito; Felix Haglund; Eiman Aleem; Olle Larsson
Journal:  J Biol Chem       Date:  2017-09-18       Impact factor: 5.157

5.  Association of insulin receptor substrate 1 with simian virus 40 large T antigen.

Authors:  Z L Fei; C D'Ambrosio; S Li; E Surmacz; R Baserga
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

6.  Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin.

Authors:  X Wu; Z Fan; H Masui; N Rosen; J Mendelsohn
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

7.  Co-immobilization of gradient-patterned growth factors for directed cell migration.

Authors:  Tracy Jane Stefonek-Puccinelli; Kristyn S Masters
Journal:  Ann Biomed Eng       Date:  2008-10-11       Impact factor: 3.934

8.  Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts.

Authors:  C Sell; G Dumenil; C Deveaud; M Miura; D Coppola; T DeAngelis; R Rubin; A Efstratiadis; R Baserga
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

9.  Increased IGFBP-1 phosphorylation in response to leucine deprivation is mediated by CK2 and PKC.

Authors:  Niyati Malkani; Kyle Biggar; Majida Abu Shehab; Shawn Shun-Cheng Li; Thomas Jansson; Madhulika B Gupta
Journal:  Mol Cell Endocrinol       Date:  2015-12-28       Impact factor: 4.102

10.  A reappraisal of the role of insulin-like growth factor I in the regulation of human hematopoiesis.

Authors:  M Z Ratajczak; W I Kuczynski; K Onodera; J Moore; J Ratajczak; D A Kregenow; K DeRiel; A M Gewirtz
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.